Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Reproduction (2003) 126 459-468
DOI: 10.1530/rep.0.1260459
Copyright © 2003 Society for Reproduction and Fertility
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ribeiro, M.
Right arrow Articles by Franchi, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ribeiro, M.
Right arrow Articles by Franchi, A

Articles

Effects of in vivo administration of epidermal growth factor (EGF) on uterine contractility, prostaglandin production and timing of parturition in rats

ML Ribeiro, M Farina, J Aisemberg, and A Franchi

Prostaglandins synthesized by cyclooxygenases elicit uterine contractions during labour. Nitric oxide synthases (NOS) produce nitric oxide (NO), which maintains uterine quiescence during pregnancy. Epidermal growth factor (EGF) interacts with prostaglandins and NO in many biological systems. The aim of this work was to study the effect of the in vivo administration of EGF on uterine contractility, prostaglandin production and timing of parturition in rats. EGF was injected into the uterine lumen of pregnant rats on day 20, 21 or 22 of gestation. Intra-uterine administration of 500 ng EGF on day 21 of gestation delayed parturition for 18 h compared with control rats. Administration of EGF was able to: (i) reduce cyclooxygenase expression in the uterus (determined by western blot analysis) and production of prostaglandins by the uterus (evaluated by conversion of [(14)C]arachidonate to labelled prostaglandins); (ii) decrease prostaglandin concentrations in amniotic fluid (radioimmunoassay); (iii) increase NO production (evaluated by conversion of [(14)C]arginine into [(14)C]citrulline); (iv) increase serum progesterone concentrations to more than control concentrations (P<0.05; radioimmunoassay); and (v) reduce the amplitude of the uterine contractions. The overall effect was a delay in the onset of delivery. This in vivo effect raises the question of whether exogenous EGF plays a role in the initiation of parturition.


This article has been cited by other articles:


Home page
 ReproductionHome page
M. G. Farina, S. Billi, G. Leguizamon, C. Weissmann, T. Guadagnoli, M. L. Ribeiro, and A. M. Franchi
Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor
Reproduction, August 1, 2007; 134(2): 355 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Mueller, T. Maltaris, J. Siemer, H. Binder, I. Hoffmann, M. W. Beckmann, and R. Dittrich
Uterine contractility in response to different prostaglandins: results from extracorporeally perfused non-pregnant swine uteri
Hum. Reprod., August 1, 2006; 21(8): 2000 - 2005.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. L. Ribeiro, J. Aisemberg, S. Billi, M. G. Farina, R. Meiss, S. McCann, V. Rettori, M. Villalon, and A. M. Franchi
Epidermal growth factor prevents prepartum luteolysis in the rat
PNAS, May 31, 2005; 102(22): 8048 - 8053.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 2003 by the Society for Reproduction and Fertility.